Horizon Therapeutics has launched its #RAREis Representation program aimed at increasing diversity, equity, and inclusion among patients with rare diseases. There are about 400 million people worldwide living with a rare disease; for many of them, access to diagnosis, care, and treatments can be challenging. Accessing better care depends on several factors, including the social determinants of health — the conditions in which people are born, grow, live, work, and age. As such, there is a disparity…
You must be logged in to read/download the full post.
The post #RAREis Representation Program Promotes Equity, Diversity appeared first on BioNewsFeeds.